EXHIBIT 13.1

                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In  connection  with the Annual  Report of China  Pharmaceuticals  International
Corporation  (the  "Company")  on Form 20-F for the period  ending  December 31,
2005, as filed with the  Securities  and Exchange  Commission on the date hereof
(the "Report"),  I, FAN Di, Chief  Executive  Officer and Acting Chief Financial
officer of the Company,  certify, pursuant to 18 U.S.C. Section 1350, as adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)    The Report fully complies with the requirements of section 13(a) or 15(d)
       of the Securities Exchange Act of 1934; and

(2)    The  information  contained  in  the  Report  fairly  presents,  in   all
       material respects, the financial condition and  results of  operations of
       the Company.



/s/ FAN DI
- -------------------------------------------
FAN Di
Chief Executive Officer
Acting Chief Financial Officer